| 2024-11-22 |
Inpatient Care and Outcomes Among People With Cancer Experiencing Homelessness |
|
|
| 2024-11-22 |
Persons With Cancer Rather Than Cancer Patients—Semantics Matter |
|
|
| 2024-11-22 |
Factors Affecting Racial and Ethnic Disparities in Colorectal Cancer Survival |
|
|
| 2024-11-22 |
Accrual to Radiotherapy Trials in the US |
|
|
| 2024-11-22 |
Standardized Definitions for Efficacy End Points for Adjuvant Trials—The Updated STEEP Criteria |
|
|
| 2024-11-22 |
Contributions to Colorectal Cancer Disparities |
|
|
| 2024-11-22 |
Recurrent Fevers in a Patient With Splenomegaly |
|
|
| 2024-11-22 |
Transperineal vs Transrectal Prostate Biopsy |
|
|
| 2024-11-22 |
Ensuring Safety and Consistency in Artificial Intelligence Chatbot Responses—Reply |
|
|
| 2024-11-22 |
Fracture Risk Prediction Using the Fracture Risk Assessment Tool in Individuals With Cancer |
|
|
| 2024-11-22 |
Ensuring Safety and Consistency in Artificial Intelligence Chatbot Responses |
|
|
| 2024-11-22 |
Mismatch Repair and Microsatellite Testing for Individuals With Colorectal Cancer |
|
|
| 2024-11-22 |
Error in Figure 1 |
|
|
| 2024-11-22 |
Error in Byline |
|
|
| 2024-11-22 |
Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for NSCLC |
|
|
| 2024-11-22 |
Stereotactic Body Radiotherapy for Medically Inoperable Early-Stage Non–Small Cell Lung Cancer |
|
|
| 2024-11-22 |
Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for NSCLC—Reply |
|
|
| 2024-11-22 |
Chimeric Antigen Receptor T Cells Targeting CD19 and GCC in Metastatic Colorectal Cancer |
|
|
| 2024-11-22 |
Oral Microbiome and Subsequent Risk of Head and Neck Squamous Cell Cancer |
|
|
| 2024-11-22 |
Cervical Cancer Incidence in the US-Affiliated Pacific Islands |
|
|
| 2024-11-22 |
Complete Response to Locoregional Therapy Plus Immunotherapy for Hepatocellular Carcinoma |
|
|
| 2024-11-22 |
Radiation-Associated Secondary Cancer in Patients With Breast Cancer |
|
|
| 2024-11-22 |
Heartbreaker |
|
|
| 2024-11-22 |
Heterogeneity of Residual Disease After Neoadjuvant Systemic Therapy in Breast Cancer |
|
|
| 2024-11-22 |
How Can Guidelines Give Clearer Guidance on Prostate Cancer Screening? |
|
|
| 2024-11-22 |
ERBB2-Low Expression in Endometrial Cancer |
|
|
| 2024-11-22 |
Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non–Small Cell Lung Cancer |
|
|
| 2024-11-22 |
Lynch Syndrome and Somatic Mismatch Repair Variants in Pancreas Cancer |
|
|
| 2024-11-22 |
Rogaratinib Plus Atezolizumab in Cisplatin-Ineligible Patients With FGFR RNA-Overexpressing Urothelial Cancer |
|
|
| 2024-11-22 |
Active Surveillance for Low-Risk Cancer |
|
|
| 2024-11-22 |
JAMA Oncology |
|
|
| 2024-10-17 |
Hormone Deprivation–Free Survival |
|
|
| 2024-10-17 |
Aspirin Use, Lifestyle Factors, and Colorectal Cancer Incidence |
|
|
| 2024-10-17 |
When Best Care Takes a Back Seat to the Bottom Line |
|
|
| 2024-10-17 |
Relapse Patterns in Early-Stage Endometrial Cancer Based on Molecular Classification—Reply |
|
|
| 2024-10-17 |
Cold Capping |
|
|
| 2024-10-17 |
Lazertinib in EGFR -Variant Non–Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors |
|
|
| 2024-10-17 |
Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer |
|
|
| 2024-10-17 |
Caring for Your Heart During Cancer Treatment |
|
|
| 2024-10-17 |
Crossing Over |
|
|
| 2024-10-17 |
Identification of Immune Checkpoint Inhibitor–Induced Diabetes |
|
|
| 2024-10-17 |
Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer |
|
|
| 2024-10-17 |
Unplanned Hospitalization Prediction During Chemoradiotherapy Via Machine Learning Classifiers—Reply |
|
|
| 2024-10-17 |
Unplanned Hospitalization Prediction During Chemoradiotherapy Via Machine Learning Classifiers |
|
|
| 2024-10-17 |
Neoadjuvant Immunotherapy |
|
|
| 2024-10-17 |
Error in Byline |
|
|
| 2024-10-17 |
Externally Controlled Studies Using Real-World Data in Patients With Hematological Cancers |
|
|
| 2024-10-17 |
Hypofractionated Postprostatectomy Radiotherapy |
|
|
| 2024-10-17 |
An Anal Lesion in a 27-Year-Old Patient |
|
|
| 2024-10-17 |
Suicide Attempt and Suicide Death Among Spouses of Patients With Cancer |
|
|
| 2024-10-17 |
Inclusion of American Indian, Alaska Native, Native Hawaiian, and Pacific Islander Patients in Clinical Trial Travel Time |
|
|
| 2024-10-17 |
Relapse Patterns in Early-Stage Endometrial Cancer Based on Molecular Classification |
|
|
| 2024-10-17 |
Inclusion of American Indian, Alaska Native, Native Hawaiian, and Pacific Islander Patients in Clinical Trial Travel Time—Reply |
|
|
| 2024-10-17 |
Hypofractionated vs Conventionally Fractionated Postmastectomy Radiation |
|
|
| 2024-10-17 |
Cardiotoxicity of Immune Checkpoint Inhibitors |
|
|
| 2024-10-17 |
Contemporary Management of Acute Myeloid Leukemia |
|
|
| 2024-10-17 |
Olaparib Without Androgen Deprivation for Biochemically Recurrent Prostate Cancer Following Prostatectomy |
|
|
| 2024-10-17 |
Graded Organ Response and Progression Criteria for Kidney Immunoglobulin Light Chain Amyloidosis |
|
|
| 2024-10-17 |
Hidden Morbidity in Cancer Care—Mental Health in Spouses |
|
|
| 2024-10-17 |
MRI-Linac–Based Radiotherapy—Promising or Hype? |
|
|
| 2024-10-17 |
Role of Lazertinib in Patients With EGFR -Variant NSCLC |
|
|
| 2024-10-17 |
Error in Abstract and Methods |
|
|
| 2024-10-17 |
JAMA Oncology |
|
|
| 2024-09-19 |
Postoperative Management of Prostate Cancer |
|
|
| 2024-09-19 |
More Benefits of Tai Chi Than Aerobic Exercise in Patients With Advanced Lung Cancer—Reply |
|
|
| 2024-09-19 |
Waterpipe Tobacco Smoking and Risk of Cancer Mortality |
|
|
| 2024-09-19 |
Measurable Residual Disease and Outcomes in Chronic Lymphocytic Leukemia |
|
|
| 2024-09-19 |
Advancing Genomic Cancer Medicine in Rural and Underserved States |
|
|
| 2024-09-19 |
Chemotherapy, Radiation Therapy, and Nasopharyngeal Carcinoma |
|
|
| 2024-09-19 |
B-Cell Maturation Antigen/CD19 Dual-Targeting Immunotherapy in Newly Diagnosed Multiple Myeloma |
|
|
| 2024-09-19 |
Exercise For Prostate Cancer |
|
|
| 2024-09-19 |
Characterizing Lung Cancer in Li-Fraumeni Syndrome |
|
|
| 2024-09-19 |
Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural Invasion |
|
|
| 2024-09-19 |
Sublobar Resection vs Lobectomy for High-Risk Stage I Non–Small Cell Lung Carcinoma |
|
|
| 2024-09-19 |
Error in Author Affiliations |
|
|
| 2024-09-19 |
JAMA Oncology |
|
|
| 2024-09-19 |
Sexual Rehabilitation Needs of Gay and Bisexual Men With Cancer |
|
|
| 2024-09-19 |
Contralateral Breast Cancer Remains a Complex Biological Conundrum |
|
|
| 2024-09-19 |
Error in Abstract |
|
|
| 2024-09-19 |
Immunotherapy Before Chemoradiotherapy—More Is Better? |
|
|
| 2024-09-19 |
Neoadjuvant Exercise Therapy in Prostate Cancer |
|
|
| 2024-09-19 |
Population-Based Incidence of Cervical Intraepithelial Neoplasia Across 14 Years of HPV Vaccination |
|
|
| 2024-09-19 |
Chemotherapy, Radiation Therapy, and Nasopharyngeal Carcinoma |
|
|
| 2024-09-19 |
Atezolizumab Before and After Chemoradiation for Unresectable Stage III NSCLC |
|
|
| 2024-09-19 |
Chemotherapy, Radiation Therapy, and Nasopharyngeal Carcinoma—Reply |
|
|
| 2024-09-19 |
Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure |
|
|
| 2024-09-19 |
Response-Adapted Ultralow-Dose Radiation Therapy for Orbital Indolent B-Cell Lymphoma |
|
|
| 2024-09-19 |
Bilateral Mastectomy and Breast Cancer Mortality |
|
|
| 2024-09-19 |
Initial Management of BRAF V600E-Variant Anaplastic Thyroid Cancer |
|
|
| 2024-09-19 |
Cara |
|
|
| 2024-09-19 |
More Benefits of Tai Chi Than Aerobic Exercise in Patients With Advanced Lung Cancer |
|
|
| 2024-09-19 |
BRCA1, BRCA2 , and Associated Cancer Risks and Management for Male Patients |
|
|
| 2024-09-19 |
A Case of Gastric Thickening and a Large Ovarian Mass |
|
|
| 2024-09-19 |
Immunotherapy vs Best Supportive Care for Patients With Hepatocellular Cancer With Child-Pugh B Dysfunction |
|
|
| 2024-09-19 |
Assessing the Environmental and Downstream Human Health Impacts of Decentralizing Cancer Care |
|
|
| 2024-09-19 |
Error in Figure 1 |
|
|
| 2024-08-15 |
Lymphoma With a Skin Rash |
|
|
| 2024-08-15 |
Immunotherapy For US Patients With Metastatic Cancer at the End of Life—Reply |
|
|
| 2024-08-15 |
Valid Analysis of Brain-Specific Progression-Free Survival |
|
|
| 2024-08-15 |
Valid Analysis of Brain-Specific Progression-Free Survival—Reply |
|
|
